Deep Tech Startups

VascVersa develops a platform for vascular stem cell therapy and cell therapy manufacturing, serving the advanced therapies and clinical development sectors in vascular biology.

2 investors

VectoFRAP is a high-frequency flow probe for aerodynamic and fluid dynamics measurements up to 5 kHz, serving aerospace, wind energy, and industrial research applications. The probe uses additive manufacturing to achieve complex internal channel designs that enable unsteady flow analysis with multi-sensor capabilities.

2 investors

Vedere Bio develops optogenetics-based gene therapies for inherited retinal diseases (IRDs) and geographic atrophy (GA), using proprietary AAV vectors for intravitreal administration to restore vision in visually impaired patients globally.

2 investors

Vellex Computing develops on-device AI training technology that enables edge devices such as satellites, robots, and drones to learn and adapt continuously at milliwatt power levels without cloud retraining. The company works at the intersection of high-performance computing and AI for edge/deep tech applications.

2 investors

Velocity Bio is developing a biophysical assay platform designed to generate larger-scale, higher-quality data for early-stage drug discovery. The platform aims to shift early discovery from blind screening toward targeted molecular design.

2 investors

Vensum develops software-defined power conversion technology for electric equipment manufacturers, enabling efficient power conversion for renewable energy, electric mobility, and energy storage applications. The company provides end-to-end design and development services using proprietary soft switching techniques to reduce losses and enable higher-frequency, more compact converter designs.

2 investors

Vergent develops tumor-targeted fluorescent imaging agents designed to enhance surgeons' ability to visualize tumors during minimally invasive and robotic-assisted cancer surgery. The company's lead program, abenacianine for injection, is in Phase 2b clinical evaluation for lung cancer surgery applications.

2 investors

Verigraft develops personalized tissue-engineered products for severe diseases, including vascular grafts, nerve grafts, and heart valves, targeting regenerative medicine markets globally. The company's proprietary technology creates biological solutions for conditions such as chronic venous insufficiency, peripheral arterial disease, and heart valve disease.

2 investors

Verogen provides NGS sequencing systems and reagent solutions for forensic and research laboratories, with offerings including the MiSeq FGx Sequencing System and flexible financing options like leasing, reagent rental programs, and bundled workflows.

2 investors

Vertical Semiconductor develops vertical gallium nitride (GaN) power semiconductors for next-generation power electronics applications. The company manufactures scalable vertical GaN technologies for data centers and power systems ranging from 40V to over 2.3kV, targeting 50% smaller footprints and 30% higher efficiency compared to conventional solutions.

2 investors

Vescent develops photonics and quantum hardware, including frequency combs, lasers, controllers, and optical atomic clocks, along with laser stabilization and cold atom science solutions. Its products serve quantum computing, precision metrology and sensing, timing, quantum networking, navigation, defense, and research applications.

2 investors

Vexlum is a spin-off from Tampere University of Technology's Optoelectronics Research Centre that develops VECSEL (vertical-external-cavity surface-emitting laser) technology, including optoelectronic materials, scalable manufacturing processes, and application-specific laser systems. Its work covers new laser wavelengths and quantum technology applications.

2 investors

ViaLase develops the ViaLase Laser System, a femtosecond laser and HD imaging platform for noninvasive interventional glaucoma treatment that creates apertures through the trabecular meshwork in patients with open-angle glaucoma. The technology, used via its FLigHT procedure, is aimed at ophthalmic surgeons treating glaucoma without incisional surgery.

2 investors

VIAR develops digital work instruction platforms for manufacturers to create, distribute, and standardize operational procedures. The company serves global manufacturing organizations seeking to improve productivity and workforce knowledge transfer.

2 investors

Videonetics builds AI-powered video computing and video management software that turns camera footage into real-time analytics for applications such as traffic management, public safety, and critical infrastructure security. Based in India, it serves government, smart city, enterprise, and sectors including BFSI and manufacturing across India, APAC, and MEA.

2 investors

viisights offers AI-based behavioral recognition technology that analyzes video to detect and understand behaviors and events. Its product True is a video analytics solution built around this behavioral recognition capability.

2 investors

Visban develops continuous millimeter-wave (mmWave) coverage technology to enable real-world deployment of wireless networks. The company focuses on making mmWave spectrum and standards practical for mobile and connectivity applications.

2 investors

VISIE develops computer vision systems for surgical robotics that enable real-time visual tracking of patient anatomy without requiring reference pins or arrays. The technology is designed for orthopedic robot manufacturers to integrate into navigation systems for surgical procedures.

2 investors

The Vision Lab creates high-density action labeling datasets for video and industrial data using proprietary vision language models combined with human annotation. The company serves machine learning teams building computer vision systems across biotech, manufacturing, and other industries.

2 investors

VISUA provides computer vision and visual AI technology for product authentication and brand protection, enabling automated verification of labels, holograms, tax stamps, and packaging using object detection via smartphone devices.

2 investors

Vitranu develops biomaterial and biologic technologies for ophthalmic applications, particularly focused on retinal and vitreoretinal diseases. The company brings medical devices and therapeutics to market for eye care professionals and patients.

2 investors

Vitroscope develops products and solutions that combine scientific expertise with product development capabilities, supported by advisors from leading research institutions. The company focuses on immunology and cell models based on its advisory team's expertise.

2 investors

Vitruvian VR builds a professional 4-axis motion simulator with a gyroscopic mechanical structure for virtual reality experiences such as flight and driving simulation. The system supports interchangeable hardware interfaces (airplane, helicopter, car, bobsled) and is designed to reduce motion sickness.

2 investors

AWAK Technologies develops a wearable peritoneal dialysis device that enables patients with end-stage renal disease to receive treatment at home or on the move, using regeneration technology that reduces dialysis fluid consumption by up to 90 percent. The company serves kidney disease patients seeking greater mobility and quality of life compared to traditional stationary dialysis machines.

2 investors